Pharmaceutical

MHRA authorises Bavarian Nordic’s chikungunya virus vaccine

The UK MHRA has granted marketing authorisation to Bavarian Nordic's Vimkunya vaccine for preventing the chikungunya virus.

May 4, 2025 - 06:00
MHRA authorises Bavarian Nordic’s chikungunya virus vaccine
The UK MHRA has granted marketing authorisation to Bavarian Nordic's Vimkunya vaccine for preventing the chikungunya virus.
Read the original article

Tags:

Previous Article

Q1 earnings pulse check: companies tentative on pharma-specific tariffs

Next Article

Entering the era of prenatal gene therapies 

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Zealand raises DKr1.45bn to advance obesity pipeline

Zealand raises DKr1.45bn to advance obesity pipeline

Jan 9, 2024

Pfizer’s multiple myeloma treatment secures conditional approval in EU

Pfizer’s multiple myeloma treatment secures conditional...

Dec 8, 2023

NHS to provide vision-saving drug to premature babies

NHS to provide vision-saving drug to premature babies

Jul 5, 2023